Search Count: 472
 |
Organism: Human immunodeficiency virus 1, Macaca mulatta
Method: ELECTRON MICROSCOPY Release Date: 2024-05-08 Classification: VIRAL PROTEIN/Immune System Ligands: NAG |
 |
Organism: Human immunodeficiency virus 1, Macaca mulatta
Method: ELECTRON MICROSCOPY Release Date: 2024-05-08 Classification: VIRAL PROTEIN/Immune System Ligands: NAG |
 |
Organism: Human immunodeficiency virus 1, Macaca mulatta
Method: ELECTRON MICROSCOPY Release Date: 2024-05-08 Classification: VIRAL PROTEIN/Immune System Ligands: NAG |
 |
Organism: Human immunodeficiency virus 1, Macaca mulatta
Method: ELECTRON MICROSCOPY Release Date: 2024-05-08 Classification: VIRAL PROTEIN/Immune System Ligands: NAG |
 |
Organism: Human immunodeficiency virus 1
Method: ELECTRON MICROSCOPY Release Date: 2024-05-08 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Human immunodeficiency virus 1, Macaca mulatta
Method: ELECTRON MICROSCOPY Release Date: 2024-05-08 Classification: VIRAL PROTEIN/Immune System Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.66 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: XWH, DMS, NA, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: XWZ, DMS, CL, NA |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: Y2C, DMS, NA, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.87 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: DMS, Y25, NA |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: DMS, Y1R, NA |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: DMS, Y1L, NA |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: DMS, Y1H, CL, NA |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.68 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: Y1C, DMS, CL, NA |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: DMS, NA, ZHA, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.92 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: DMS, Y0W, NA |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.55 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: Y3N, DMS, NA, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.56 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: VXQ, DMS, NA, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: DMS, Y0S, NA, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.68 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: DMS, Y0O, SO4, MG |